Treatment with TUG1-DDS markedly reduced tumour growth compared with control-DDS (CTRL-DDS) together with the downregulation of TUG1 expression (Fig. 7g, P=5.451 × 10–5). This evidence concerns the gene TUG1 and neoplasm.